Minimizing Lung Injury During Laparoscopy in Steep Trendelenburg Position
NCT ID: NCT04900714
Last Updated: 2022-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2021-06-21
2021-09-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In patients with steep Trendelenburg and a pneumoperitoneum, the investigators aim to
1. measure apical versus basal atelectasis using the lung ultrasound score
2. compare lung ultrasound scores at different PEEP levels
3. compare respiratory mechanics at the different PEEP levels
4. contrast the optimal PEEP level to standard practice
5. provide guidance to optimal PEEP titration in this setting for the clinician
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trendelenburg Study
NCT01979575
Transpulmonary Pressure Under Stressing Conditions
NCT03746236
Transpulmonary Driving Pressure and Intra-abdominal Pressure Relationship During Laparoscopic Surgery
NCT03435913
Influence of Tidal Volume on Postoperative Pulmonary Function
NCT00795964
Prevention of Perioperative Pulmonary Complications by Lung Recruitment During Laparoscopic Surgery
NCT04728945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Incorrect intra-operative ventilator management can be harmful for the patient, potentially leading to postoperative pulmonary complications and ventilator-induced lung injury. During routine anesthesia procedures, most anesthetists will set the ventilator by rule of thumb with a PEEP of 4-6 cmH2O, a tidal volume of 6-8 ml/kg of ideal body weight and a frequency of 10-15 breaths per minute in order to provide lung protective ventilation. However, due to recent advances in surgical practice, patients are more frequently placed in non- physiological states, such as Trendelenburg position up to 30° with concurrent pneumoperitoneum and intra-abdominal pressures of 15mmHg or higher, as in for example robot-assisted radical prostatectomy or gynecological procedures. This extreme positioning and increased intra-abdominal pressure can have a significant effect on respiratory mechanics and can potentially result in excessive lung stress. The changes in applied positive pressure ventilation will result in changes of regional ventilation: both an increased amount of atelectasis and an increased amount of regional hyperinflation are observed in this setting. The ideal PEEP level balances the recruitment of atelectasis versus excessive hyperinflation. These changes in regional ventilation can be assessed by lung ultrasound. The lung ultrasound score can distinguish atelectasis from normal aeration in the different lung regions of interest.
This project is designed as a single center cohort study. Non-obese (BMI \< 30kg/m2), lung-healthy non-pregnant, non-smoking individuals without right sided heart failure, scheduled for elective laparoscopy of the lower abdomen, will be recruited. Standardized induction and maintenance with propofol TCI (3-6μg/l plasma concentration as calculated by the Marsh model), sufentanil (0.2μg/kg) and rocuronium (0.6mg/kg) will be provided. Neuromuscular blockade will be monitored using a train-of-four (TOF) monitor and kept with a TOF count \< 1 throughout the study using additional doses if indicated. A radial arterial line will be placed. Mechanical ventilation will be provided in volume control mode with a tidal volume of 4-6 ml/kg of ideal body weight (IBW) aiming for a driving pressure ≤ 15cmH2O, a starting PEEP of 5cmH2O, a frequency of 12-18 breaths per minute titrated to the end-tidal CO2 measurement and an initial FiO2 of 0.4. An esophageal balloon catheter with pressure sensor will be used to calculate transpulmonary pressures. The balloon and pressure sensor will be calibrated as per manufacturers guideline. Respiratory parameters will be recorded and saved for later evaluation using the FluxMed GrT monitor and software (MBMED, Argentina). After inflation of the pneumoperitoneum, lung ultrasound will be performed bilaterally at the midclavicular line between the second and third ribs, at the posterior axillary line above the level of T4 and at the posterior axillary line closely superior to the diaphragm, thus retaining 6 ultrasound loops which will be saved for post-hoc lung ultrasound scoring. The lung ultrasound measurements will be repeated at different decremental levels of PEEP: 15, 10, 5 and 0 cmH2O respectively. Arterial blood gas analysis will be performed before insufflation of the pneumoperitoneum and repeated at each level of PEEP. A minimum of 4 minutes equilibration time will be provided after changing PEEP.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Decremental PEEP
Every participant will be exposed to a stepwise decremental PEEP.
Decremental PEEP
High PEEP to low PEEP.
Lung ultrasound score
lung ultrasound to determine the extend of atelectasis. Uses validated lung ultrasound score.
Blood gas analysis
Blood gas analysis to determine arterial oxygen tension
Registration of respiratory mechanics
Pressures and volumes will be registered by the Fluxmed respiratory monitor (MBMED, Argentina)
Evaluation of dead space
Dead space will be measured non-invasively using volumetric capnography on the FluxMed respiratory monitor (MBMED, Argentina)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Decremental PEEP
High PEEP to low PEEP.
Lung ultrasound score
lung ultrasound to determine the extend of atelectasis. Uses validated lung ultrasound score.
Blood gas analysis
Blood gas analysis to determine arterial oxygen tension
Registration of respiratory mechanics
Pressures and volumes will be registered by the Fluxmed respiratory monitor (MBMED, Argentina)
Evaluation of dead space
Dead space will be measured non-invasively using volumetric capnography on the FluxMed respiratory monitor (MBMED, Argentina)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* lung disease (e.g. asthma, COPD, emphysema)
* BMI \> 30 kg/m2
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Antwerp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vera Saldien, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Head of the department of anesthesiology
Tom Schepens, MD, PhD
Role: STUDY_CHAIR
Anesthetist/intensivist
Gregory De Meyer, MD
Role: STUDY_CHAIR
Anesthetist in training
Stuart G Morrison, MD
Role: STUDY_DIRECTOR
Staff anesthetist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Antwerp University Hospital
Edegem, Antwerp, Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
De Meyer GRA, Morrison SG, Saldien V, Jorens PG, Schepens T. Minimizing Lung Injury During Laparoscopy in Head-Down Tilt: A Physiological Cohort Study. Anesth Analg. 2023 Oct 1;137(4):841-849. doi: 10.1213/ANE.0000000000006325. Epub 2022 Dec 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1378
Identifier Type: OTHER
Identifier Source: secondary_id
20/40/516
Identifier Type: OTHER
Identifier Source: secondary_id
20/40/516
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.